Compare

Two peptides, one row at a time.

Pick any two indexed peptides. The URL captures your selection - paste it in a deck, an email, a paper. The view stays the same for any reader who opens it.

Identity
  • Sequence
    YLRIVQCRSVEGSCGF
    GEPPPGKPADDAGLV
  • Length
    16 aa
    15 aa
  • Molecular weight
    1815.13
    1419.55
  • Modifications
    disulfide C7-C15tyrosine-extended hGH C-terminal fragment
    acetyl-N-terminus
  • Mechanism

    Modified C-terminal fragment of hGH (residues 176-191); preclinically lipolytic but failed to demonstrate clinical weight loss in Phase 2 trials.

    Pentadecapeptide derived from human gastric juice; modulates VEGF and growth-hormone receptor expression in injured tissue.

Provenance
  • BioGate
    warningBioGate · AMBER
    verifiedBioGate · GREEN
  • PDA-V1 outer
  • Inputs hash
  • Model version
    structure-fm-2026.04
    structure-fm-2026.04
  • PDA candidates
    5
    4
Outcomes
  • RWE cohorts
    6
    5
  • Total participants
    459
    270
  • Primary endpoint Δ
    +1.09 Δ HRV ms (8-week)
    95% CI [0.64, 1.54]
    -1.7 Δ HRV ms (8-week)
    95% CI [-2.46, -0.94]
  • LOO posterior
    68.7%
    β(51.8, 23.6)
    88.1%
    β(33.8, 4.6)
  • Top-grade citations
    Grade C0 of 1
    Grade B2 of 2
Economics
  • IPNFT
    unminted
    Molecule IPNFT V2
    Solana · 73 holders
  • Royalty cascade
    -
    10.04%
Indications
  • Listed indications
    • · lipolysis research
    • · obesity (negative Phase 2 outcome)
    • · soft-tissue recovery
    • · GI mucosal repair
    • · tendon healing